Cover for Article 9: Training and Awareness Domain of the Clinical Trial Disclosure Maturity Model

Article 9 in our Maturity Model series

Executive Summary

The training and awareness domain focuses on developing and maintaining the knowledge, skills, and understanding necessary for effective clinical trial disclosure across an organization. This domain encompasses comprehensive training programs, strategies for raising awareness about disclosure requirements and best practices, and methods for assessing and improving disclosure competency.


Why this domain matters

Well-informed staff across various functions enhance an organization’s ability to meet regulatory requirements and streamline disclosure processes. Training programs help mitigate risks, reduce errors, and promote consistent disclosure practices by fostering a culture of transparency and compliance. In an evolving regulatory landscape, ongoing education ensures that organizations can adapt quickly to new requirements and industry best practices, enhancing their reputation for transparency. Training and awareness in clinical trial disclosure are helpful for several reasons:


Read more

Take the Maturity Model Self-Assessment

This interactive tool will guide you through a comprehensive evaluation of your organization's disclosure practices, enabling you to identify strengths, pinpoint areas for improvement, and chart a clear path toward greater transparency and compliance.

Take our interactive Maturity Model Survey.

About the author

Headshot of Thomas Wicks.

Thomas Wicks

Head of Transparency Operations, Citeline

ライフサイエンス分野で20年以上の経験を持つ戦略リーダーであり、現在はCitelineの透明性業務責任者を務めています。業界をリードするTrialScopeの情報開示ソリューションの戦略を指揮し、透明性に関する深い知識と実績を持っています。

トーマスは、情報開示要件や透明性のトレンドについてのオピニオンリーダーとしても高く評価されており、これまでに60以上のカンファレンスで講演し、40以上の出版物を執筆しています。また、裁判の透明性を尊重するソリューションを加速させることを使命とし、チームに力を与えることに情熱を注いでいます。

Related resources

Biopharma professional on laptop browsing Pink Sheet for global policy and regulatory insights.
MAY 01, 2022
eBook
薬事規制関連支援サービス

Your Keys to Understanding EU Transparency

A collection of Pink Sheet articles covering evolving EU regulations on clinical trial disclosure and transparency

Hands with a digital icon for security hovering above them.
SEP 01, 2023
Whitepaper
薬事規制関連支援サービス

Clinical Trial Disclosure Compliance a Moving Target Due to Ever-changing Global Regulations

Gain insights on key factors driving disclosure rule updates and ways to minimize noncompliance risks.

The Clinical Trial Disclosure Maturity Model: a Framework for Excellence
SEP 30, 2024
Article
薬事規制関連支援サービス

Citeline Maturity Model for Clinical Trial Disclosure: a Framework for Excellence

The clinical trial disclosure maturity model is a comprehensive framework designed to help organizations assess and improve their disclosure practices.